Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients
Clinical trial NCT03456999 · WITHDRAWN
Trial details
- NCT number
- NCT03456999
- Sponsor
- Novartis Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-07-13
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.